tracking the news, one byte at a time
Freak Pulse

Treatment Access, Policy, and Emerging Therapies this week: This matters for Alzheimer’s Disease and Frontal Temporal Dementia because it gives a concrete current signal to; and The evidence base for cannabis as an ADHD treatment is…

Anavex Life Sciences presented new long-term data for its investigational oral therapy blarcamesine (Anavex 2-73) at the 2026 International Conference on Alzheimer’s and Parkinson’s Diseases.